2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow VES001: new trials by email Literature Review of VES001 trials Research Report on VES001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 VES001 - Dementia, Frontotemporal Dementia | Phase 1 | Completed | Mads Kjolby | 6 | 2024-12-12 | 2025-08-24 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants VES001, Placebo - Dementia, Frontotemporal | Phase 1 | Completed | Vesper Biotechnologies ApS | 78 | 2023-10-11 | 2024-08-22 |
Frontotemporal Dementia (2) · Asymptomatic Diseases (1) · Dementia (1)
Mads Kjolby (1) · Vesper Biotechnologies ApS (1)
Netherlands (2) · United Kingdom (1)
Mads Kjoelby, MD, PhD (1) · Mads Kjolby, MD, PhD (1)